Emergent BioSolutions Inc. — Investor Relations & Filings
Filings indexed
1,264
across all filing types
Latest filing
2019-02-27
Regulatory Filings
Country
US
United States of America
Listing
US
EBS
Emergent BioSolutions Inc. is a life sciences company specializing in solutions for public health threats. The company develops, manufactures, and delivers medical countermeasures for national security and public health preparedness, addressing threats such as anthrax, smallpox, botulism, and Ebola. In addition to its biodefense portfolio, Emergent provides commercial products for endemic health crises, notably the opioid epidemic. The company also offers contract development and manufacturing services through strategic partnerships, leveraging its specialized capabilities to support biopharmaceutical innovators, governments, and non-governmental organizations.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Regulatory Filings 2019 | 2019-02-27 | English | |
| Annual Report 2018 | 2019-02-22 | English | |
| Regulatory Filings 2019 | 2019-02-21 | English | |
| FORM 4/A SUBMISSION | 2019-02-21 | English | |
| Regulatory Filings 2019 | 2019-02-12 | English | |
| Major Shareholding Notification 2019 | 2019-02-11 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2019
12 filings
| |||||
| 11997908 | Regulatory Filings 2019 | 2019-02-27 | English | ||
| 11997912 | Annual Report 2018 | 2019-02-22 | English | ||
| 11997913 | Regulatory Filings 2019 | 2019-02-21 | English | ||
| 11997915 | FORM 4/A SUBMISSION | 2019-02-21 | English | ||
| 11997914 | Regulatory Filings 2019 | 2019-02-12 | English | ||
| 11997917 | Major Shareholding Notification 2019 | 2019-02-11 | English | ||
| 11997919 | SCHEDULE 13G/A | 2019-02-08 | English | ||
| 11997920 | Major Shareholding Notification 2019 | 2019-01-28 | English | ||
| 11997921 | Regulatory Filings 2019 | 2019-01-24 | English | ||
| 11997927 | Regulatory Filings 2019 | 2019-01-12 | English | ||
| 11997926 | Regulatory Filings 2019 | 2019-01-07 | English | ||
| 11997931 | 8-K | 2019-01-04 | English | ||
|
2018
3 filings
| |||||
| 11997929 | Regulatory Filings 2018 | 2018-12-17 | English | ||
| 11997932 | 8-K/A | 2018-12-12 | English | ||
| 11997933 | 8-K/A | 2018-12-12 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Emergent BioSolutions Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32870/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32870 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32870 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32870 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32870}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Emergent BioSolutions Inc. (id: 32870)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.